THE GLOBAL BLOOD GLUCOSE MONITORING CONSUMABLES MARKET SIZE TO REACH USD 29 BILLION BY 2026, GROWING AT A CAGR OF 13% DURING 2021-2026

Blood Glucose Monitoring Consumables Market Size, Share, Trends Analysis Report by Products (Test Strips, Lancets & Lancing Devices, and Sensors); Distribution Channels (Offline and Online); End-users (Hospitals & Clinics, Individuals, and Others); and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa); Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021–2026

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

263 Pages

98 Tables

142 Charts

5 Regions

20 Countries

36 Companies

4 Market Segment

GLOBAL BLOOD GLUCOSE MONITORING CONSUMABLES MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 29 BILLION (2026)
CAGR 13% (2021-2026)
Base Year 2020
Forecast Year 2021–2026
Market Segments Products (Test Strips, Lancets & Lancing Devices, and Sensors); Distribution Channels (Offline and Online); End-users (Hospitals & Clinics, Individuals, and Others)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, Columbia, Saudi Arabia, Turkey, South Africa, and Iran

BLOOD GLUCOSE MONITORING CONSUMABLES INDUSTRY INSIGHTS

The global blood glucose monitoring consumables market size was valued at USD 14.14 billion to reach USD 29 billion by 2026, growing at a CAGR of 13% during the forecast period. The market has witnessed significant growth due to the growing prevalence of diabetes and the increasing awareness of self-management of diabetes.

The prevalence of diabetes worldwide increases at an alarming rate due to changing lifestyles, growing alcohol consumption, and increasing smokers. However, the outbreak of the COVID-19 pandemic and the introduction of advanced test strips and lancets influence the digital diabetes management market's growth. The increased demand for self-care/homecare devices is also contributing to the usage of BGM consumables. With an increase in the sale of blood glucose meters, test strips, and lancets, the market offers tremendous growth opportunities for global, regional, and local vendors. Therefore, many vendors strategically focus on the development and commercial launches for regular blood glucose monitoring, which increases the demand for consumables.

SNIPPETS

  • Test strips are likely to reach a revenue share of over USD 13 billion by 2026 due to the high application of these consumables among hospitals and individual patients.
  • Sensors are expected to grow at the highest CAGR of approx. 28% during the period 2020–2026 on account of the increasing popularity of non and minimal-invasive devices.
  • Online distribution channels project to observe an incremental growth of approx. USD 9 billion by 2026 due to the digitization of pharmacies and the outbreak of the COVID-19 pandemic.
  • Hospitals and clinics expect to grow at a CAGR of approx. 11% by 2026 because of the high consumption of consumables such as test strips and lancets in these settings.
  • North America is projected to touch revenue over approx. USD 15 billion by 2026 due to the high prevalence of the diabetic population and increased awareness of consumables.

GLOBAL BLOOD GLUCOSE MONITORING CONSUMABLES MARKET SEGMENTATION

This research report includes a detailed segmentation by

  • Products
  • End-users
  • Distribution Channel
  • Geography

INSIGHTS BY PRODUCTS 

Test strips accounted for over 64% of the global blood glucose monitoring consumables market in 2020. As revenues from test strips are recurring, vendors strategize to maximize sales volume and profit margins by offering innovative products. However, the growing use of self-monitoring blood glucose testing by patients and professionals in several POC testing sites such as emergency care, physician offices, ambulatory settings, and nursing homes increases test strips' consumption. Hospitals across the world have been using test strips for superfast output and nearly accurate results. These factors have increased the demand for test strips in the market.

The continuous glucose monitoring (CGM) sensors segment is likely to grow at an incremental revenue of over USD 10 billion by 2026. The incorporation of smart and user-friendly features with increased accuracy expect to drive the application of sensors. The introduction of non- and minimal invasive sensors is also boosting the market growth. Manufacturers are using electrochemical, optical, piezoelectric-based sensors in the commercialized CGM systems. The use of minimally invasive CGM sensors using the electrochemical sensing technique is on the rise. However, over the past decade, commercial-grade CGM sensors have lost their steam compared to SMBG systems. Vendors are focusing on developing advanced, accurate sensors. One of the major factors driving the growth of sensors is the size reduction and increased lifespan of these devices, which are considered essential factors for high adoption.

INSIGHTS BY END-USERS 

In 2020, the end-user segment was segmented into individuals, hospitals and clinics, and others. The individual's segment accounted for the highest share of the market with 75%. The individual segment accounts for the highest share due to the wide acceptance of SMBG monitoring devices and consumables such as test strips, lancets, and lancing devices among consumers. The acceptance of these consumables and machines is confined to developed countries and in developing and underdeveloped countries, which has influenced their revenue growth. SMBG and continuous glucose monitoring devices use sensors, lancets, lancing devices, and test strips as consumables to measure blood glucose. The usage of CMBG is higher in developed countries such as the US and UK, France, Spain, Italy, and Germany due to the increased awareness of these devices and reimbursement options.

The global blood glucose monitoring consumables market by hospitals & clinics is expected to reach approx. USD 5 billion by 2026. Consumables have been widely used devices in ambulatory settings and hospitals. They became a preferred choice among medical professionals during the COVID-19 pandemic for monitoring blood glucose levels. The use of BGM devices among professionals in hospitals and clinics is also on the rise. Furthermore, the introduction of favorable government initiatives and reimbursement options for blood glucose monitoring are fueling the market growth.

INSIGHTS BY DISTRIBUTION CHANNEL 

Online distribution channels are increasing significantly, although retail channels are maintaining their lead. Online purchasing channels expect to grow at a CAGR of over 12% during the forecast period. However, retail stores continue to be preferred for purchasing consumables and BGM devices in low- and middle-income countries. As the older generation patients prefer retail chains to purchase blood glucose consumables, the X generation prefers online channels for consumables due to high smartphone penetration. With the outbreak of the COVID-19 pandemic, most offline pharmacies were closed, which directly boosted consumables' sales via online channels. Hospital pharmacies, standalone pharmacies, and other retail pharmacies are the primary retail offline mode of distribution. Around 80% of BGM devices & consumables sales occur via retail channels in low- and middle-income countries.

INSIGHTS BY GEOGRAPHY

In 2020, North America dominated the market due to its developed healthcare infrastructure and increased awareness of diabetics among patients. The usage of continuous blood glucose monitoring sensors, test strips, lancets, and lancing devices is high among patients. The impact of COVID-19 has been increased in the region, with the US accounting for the highest infection rates.

In 2020, Europe was the second-largest contributor and accounted for approx. 30% in the blood glucose monitoring consumables market share. Germany occupies the largest market share in the Europe region. Healthcare facilities, availability of reimbursement policies, and increasing prevalence are promoting growth in the market. In the APAC region, growing population and diabetes prevalence are considered major contributors to the blood glucose monitoring consumables market growth. In the APAC region, the test strips, lancets, and lancing devices are high compared to the CGM sensors in the market.

INSIGHTS BY VENDORS

Medtronic, F. Hoffmann-La Roche, LifeScan, Abbott Laboratories, and Ascensia are the major global players in the blood glucose consumables market. New product approvals/launches coupled with increased R&D activities are the major strategies implemented by vendors to expand presence, drives the market growth, and sustain the market position. Vendors are actively launching innovative devices to penetrate and tap the high growth potential of the market. Vendors are aggressively engaged in R&D activities and plan to launch several innovative products in the coming years. For instance, Abbott, F. Hoffmann-La Roche, Medtronic, Dexcom, LifeScan, and Ascensia Diabetes Care dominate the market due to continuous product innovations and launches. Several companies are developing or commercializing products such as CGM sensors with increased lifespan, advanced test strips, lancets, and lancing devices, respectively, for continuous and self-monitoring blood glucose devices in the market.

The global blood glucose monitoring consumables market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Product

  • Test Strips
  • Lancets and Lancing Devices
  • Sensors

Distribution Channels

  • Offline
  • Online

End-users

  • Hospitals & Clinics
  • Individuals
  • Others

Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • South Africa
    • Iran

Frequently Asked Questions

The global blood glucose monitoring consumables market is expected to grow at a CAGR of 13% during the forecast period.
The global blood glucose monitoring consumables market size was valued at USD 14.14 billion to reach USD 29 billion by 2026.
The European blood glucose monitoring consumables market is expected to grow at a CAGR of over 11% during 2020–2026.
Abbott, F. Hoffmann-La Roche, Dexcom, Medtronic, Ascensia Diabetes Care Holding, and LifeScan are the key vendors in the market.
In terms of products, test strips accounted for over $9 billion in revenue share in 2020.
Download Free Sample
Read More

Select a license type that suits your business needs

Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Select a license type that suits your business needs

Best Value Tag
Coming Soon
  • Stay tuned with us.

YOU CAN GET A FREE SAMPLE OF THIS REPORT!

Fill out your details & get your free sample

Our Clients

Licence Types What are these?

Our Clients Speak

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date